TCL Archive NCI: The Times Have Been “Confusing,” Acting NCI Director Niederhuber Admits in Memo. June 9, 2006
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983